Peptide lipidation stabilizes structure to enhance biological function

NMRPipe: A multidimensional spectral processing system based on UNIX pipes

Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961

NMR with Proteins and Nucleic Acids

Wüthrich, K. (1986) · Europhysics news · doi:10.1051/epn/19861701011 · Cited by 8,028

NMR of Proteins and Nucleic Acids

(2006) · Royal Society of Chemistry eBooks · doi:10.1039/9781847555236-00336 · Cited by 5,874

Using circular dichroism spectra to estimate protein secondary structure

Greenfield, N. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.202 · Cited by 4,123

Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids

Fields, G., & NOBLE, R. L. (1990) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,490

The Xplor-NIH NMR molecular structure determination package

Schwieters, C. D., Kuszewski, J. J., Tjandra, N., & Clore, G. M. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(02)00014-9 · Cited by 2,371

BioMagResBank

Ulrich, E. L., Akutsu, H., Doreleijers, J. F., Harano, Y., Ioannidis, Y., Lin, J. C., Livny, M., Mading, S., Maziuk, D., Miller, Z., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm957 · Cited by 1,472

Molecular and Cellular Endocrinology

Rainey, W. E., & Rodgers, R. J. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.10.007 · Cited by 1,340

Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions

Greenfield, N. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.204 · Cited by 886

Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration

Knudsen, L. B., Nielsen, P. F., Huusfeldt, P. O., Johansen, N. L., Madsen, K., Pedersen, F. Z., Thøgersen, H., Wilken, M., & Agersø, H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9909645 · Cited by 711

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641

Principles of physical biochemistry

Holde, K. E. V., Johnson, W. C., & Ho, P. S. (1998) · Cited by 580

Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation

Kang, R., Wan, J., Arstikaitis, P., Takahashi, H., Huang, K., Bailey, A. O., Thompson, J. X., Roth, A. F., Drisdel, R. C., Mastro, R., et al. (2008) · Nature · doi:10.1038/nature07605 · Cited by 533

Large-scale profiling of protein palmitoylation in mammalian cells

Martin, B. R., & Cravatt, B. F. (2009) · Nature Methods · doi:10.1038/nmeth.1293 · Cited by 511

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

Havelund, S., Plum, A., Ribel, U., Jonassen, I., Vølund, A., Markussen, J., & Kurtzhals, P. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036926.54824.37 · Cited by 431

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., Du, X., Petrov, A., Lassman, M. E., Jiang, G., et al. (2009) · Diabetes · doi:10.2337/db09-0278 · Cited by 409

Protein palmitoylation and subcellular trafficking

Aicart-Ramos, C., Valero, R. A., & Rodríguez‐Crespo, I. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.009 · Cited by 387

Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation

Lin, D.-T., Makino, Y., Sharma, K., Hayashi, T., Neve, R., Takamiya, K., & Huganir, R. L. (2009) · Nature Neuroscience · doi:10.1038/nn.2351 · Cited by 347

Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonance

Braun, W. A., Wider, G., Lee, K. H., & Kurt Wüthrich, A. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80143-0 · Cited by 340

Structure-activity studies of glucagon-like peptide-1.

Adelhorst, K., Hedegaard, B. B., Knudsen, L. B., & Kirk, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37366-0 · Cited by 286

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273

Evaluation of a Quantitative Magnetic Resonance Method for Mouse Whole Body Composition Analysis

Tinsley, F. C., Taicher, G. Z., & Heiman, M. L. (2004) · Obesity Research · doi:10.1038/oby.2004.20 · Cited by 244

Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness

Madsen, K., Knudsen, L. B., Agersoe, H., Nielsen, P. F., Thøgersen, H., Wilken, M., & Johansen, N. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070861j · Cited by 244

Passing the baton in class B GPCRs: peptide hormone activation via helix induction?

Parthier, C., Reedtz‐Runge, S., Rudolph, R., & Stubbs, M. T. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.02.004 · Cited by 193

Dynamic structure of membrane-anchored Arf•GTP

Liu, Y., Kahn, R., & Prestegard, J. H. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1853 · Cited by 139

Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue

Russell-Jones, D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.018 · Cited by 137

Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents

Day, J. W., Gelfanov, V., Smiley, D., Carrington, P. E., Eiermann, G., Chicchi, G., Erion, M. D., Gidda, J., Thornberry, N. A., Tschöp, M. H., et al. (2012) · Peptide Science · doi:10.1002/bip.22072 · Cited by 133

Effect of Phosphorylation on α-Helix Stability as a Function of Position

Andrew, C. D., Warwicker, J., Jones, G. R., & Doig, A. J. (2002) · Biochemistry · doi:10.1021/bi0113216 · Cited by 133

Trifluoroethanol may form a solvent matrix for assisted hydrophobic interactions between peptide side chains

Reiersen, H., & Rees, A. R. (2000) · Protein Engineering Design and Selection · doi:10.1093/protein/13.11.739 · Cited by 119

Palmitoylated Cysteine 341 Modulates Phosphorylation of the β2-Adrenergic Receptor by the cAMP-dependent Protein Kinase

Moffett, S., Adam, L., Bonin, H., Loisel, T. P., Bouvier, M., & Mouillac, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21490 · Cited by 114

[1] Concept and early development of solid-phase peptide synthesis

Merrifield, R. B. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)89040-4 · Cited by 106

Structure of Glucagon-Like Peptide(7-36) Amide in a Dodecylphosphocholine Micelle as Determined by 2D NMR

Thornton, K. H., & Gorenstein, D. G. (1994) · Biochemistry · doi:10.1021/bi00178a009 · Cited by 102

Interplay of Palmitoylation and Phosphorylation in the Trafficking and Localization of Phosphodiesterase 10A: Implications for the Treatment of Schizophrenia

Charych, E. I., Jiang, L.-X., Lo, F., Sullivan, K., & Brandon, N. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1635-10.2010 · Cited by 98

Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C

Johansson, J., Nilsson, G., Strömberg, R., Robertson, B., Jörnvall, H., & Curstedt, T. (1995) · Biochemical Journal · doi:10.1042/bj3070535 · Cited by 93

Phosphorylation destabilizes α-helices

Szilák, L., Moitra, J., Krylov, D. Y., & Vinson, C. (1997) · Nature Structural Biology · doi:10.1038/nsb0297-112 · Cited by 84

Multiple-site replacement analogs of glucagon. A molecular basis for antagonist design.

Unson, C. G., Wu, C. R., Fitzpatrick, K., & Merrifield, R. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99910-2 · Cited by 45

Farnesylation of the SNARE Protein Ykt6 Increases Its Stability and Helical Folding

Pylypenko, O., Schönichen, A., Ludwig, D., Ungermann, C., Goody, R. S., Rak, A., & Geyer, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.099 · Cited by 43

Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase

Krstenansky, J. L., Trivedi, D. B., & Hruby, V. J. (1986) · Biochemistry · doi:10.1021/bi00361a014 · Cited by 39

The bioactive conformation of glucose‐dependent insulinotropic polypeptide by NMR and CD spectroscopy

Alaña, I., Malthouse, J. P. G., O'Harte, F. P. M., & Hewage, C. M. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21372 · Cited by 35

Site-specific Effects of Peptide Lipidation on β-Amyloid Aggregation and Cytotoxicity

Qahwash, I. M., Boire, A. A., Lanning, J. D., Krausz, T. N., Pytel, P., & Meredith, S. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702146200 · Cited by 22

Positively Charged Residues at Positions 12, 17, and 18 of Glucagon Ensure Maximum Biological Potency

Unson, C. G., Wu, C.-R., Cheung, C. P., & Merrifield, R. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10308 · Cited by 22

Functional association of the N‐terminal residues with the central region in glucagon‐related peptides

Patterson, J. T., Day, J. W., Gelfanov, V. M., & DiMarchi, R. D. (2011) · Journal of Peptide Science · doi:10.1002/psc.1385 · Cited by 16

Stabilization of conformationally dynamic helices by covalently attached acyl chains

Poschner, B. C., & Langosch, D. (2009) · Protein Science · doi:10.1002/pro.155 · Cited by 13

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

Finan, B., Yang, B., Ottaway, N., Smiley, D. L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K. M., Fischer, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3761 · Cited by 645

Factors affecting the physical stability (aggregation) of peptide therapeutics

Zapadka, K. L., Becher, F. J., dos Santos, A. L. G., & Jackson, S. (2017) · Interface Focus · doi:10.1098/rsfs.2017.0030 · Cited by 425

Prebiotic Peptides: Molecular Hubs in the Origin of Life

Frenkel-Pinter, M., Samanta, M., Ashkenasy, G., & Leman, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00664 · Cited by 354

Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics

Erak, M., Bellmann‐Sickert, K., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.012 · Cited by 327

Antimicrobial peptides: an alternative for innovative medicines?

da Costa, J. P., Cova, M. M., Ferreira, R. M., & Vitorino, R. M. P. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6375-x · Cited by 212

Innovative use of fatty acid acylation to enhance biological action and biophysical properties of peptide therapeutics

Ward, B. P. (2012) · ProQuest Demo Repository

Lipidation and conformational constraining for prolonging the effects of peptides: Xenopus glucagon-like peptide 1 analogues with potent and long-acting hypoglycemic activity

Han, J. D. J., Huang, Y., Chen, X., Zhou, F. L., Fei, Y., & Fu, J. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.032 · Cited by 19

Effect of Lipidation on the Structure, Oligomerization, and Aggregation of Glucagon-like Peptide 1

Brichtová, E. P., Edu, I. A., Li, X., Becher, F. J., dos Santos, A. L. G., & Jackson, S. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00484 · Cited by 38

Neoglycolipids for Prolonging the Effects of Peptides: Self-Assembling Glucagon-like Peptide 1 Analogues with Albumin Binding Properties and Potent in Vivo Efficacy

van Witteloostuijn, S. B., Mannerstedt, K., Wismann, P., Bech, E. M., Thygesen, M. B., Vrang, N., Jelsing, J., Jensen, K. J., & Pedersen, S. L. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00787 · Cited by 33

Molecular design of peptide therapeutics via N-terminal modification

Sürmeli, D., Dinsmore, T. C., Anchukaitis, H. M., Montanari, V., Beinborn, M., & Kumar, K. (2024) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2024.04.011 · Cited by 4